Patent · US Active

Anti c-Met antibodies

US8637027B2 · kind B2 · utility

9Cited by

11References

21Claims

0Family size

Assignee

argenx BV · BE

Inventors

Anna Hultberg · Sint-Martens-Latem, BE
Michael John Scott Saunders · Wondelgem, BE
Johannes Joseph Wilhelmus De Haard · Vlaardingen, NL
Els Festjens · Zwevegem, BE
Natalie De Jonge · Zwijnaarde, BE
Paolo Michieli · L'Aquila, IT
Cristina Basilico · San Mauro Torinese, IT
Torsten Dreier · Breda, NL

Key dates

Filing date	Nov 3, 2011
Grant date	Jan 28, 2014
Priority date	—
Expiry date	Nov 3, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies that specifically bind to the human c-Met receptor protein and that act as strict antagonists of hepatocyte growth factor (HGF)-mediated activation of the c-Met receptor and also inhibit HGF-independent activation of the human c-Met protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.